4,633 results on '"Borden A"'
Search Results
2. INTRODUCTION
3. Essential Being or Unity Less than Numerical Unity? Stein and Scotus on the Universal
4. Calderón Onstage in Spanish Florida: Context, Text, and Reconstruction
5. Rooted in Relationships, Building University-School District Partnerships
6. A multi-Physics Experiment for Low-Yield Nuclear Explosion Monitoring
7. Performance, Risk and the Public Realm
8. Performance Monitoring and Performance Management Systems
9. Knowing Different Cities
10. Nerve Blocks in a Patient With Multiple Sclerosis
11. Qualitative and Quantitative Predictions and Measurements of Singlet-Triplet Splittings in Non-Kekulé Hydrocarbon Diradicals and Heteroatom Derivatives
12. It Takes a Village: A Planned Initiative Toward Language Program Revitalization
13. Transcending the Black Swan: From Self to System
14. Second Harmonic Generation Microscopy of Electromechanical Reshaping on Corneal Collagen
15. Yoga and eating disorder prevention and treatment: a comprehensive review and meta-analysis
16. Centering the Lens of Social Justice
17. Inhibition of EGFR/ErbB does not protect against C. difficile toxin B
18. Extracting the Affective Content of Fidgeting in Adults with ADHD via Machine Learning and a Hand-held Soft Tangible Device
19. Fishing damage to cloud sponges may lead to losses in associated fish communities in Pacific Canada
20. Early Detection of Precursor Diseases of Multiple Myeloma
21. Characterization of an advanced bone graft material with a nanocrystalline hydroxycarbanoapatite surface and dual phase composition
22. Novel Approach to Directly Sample Lung-Specific Volatile Organic Compounds in Exhaled Breath
23. Correlation Mapping of the Human Respiratory Tract Microbiome Reveals Lung-Specific Indicators and Subnetworks
24. Introduction. Fanning the flames of artificial intelligence in the media: beyond efficiency and productivity gains
25. Effect of Poly(ethylene glycol) Configuration on Microbubble Pharmacokinetics
26. The time course of hypoxia effects using an aviation survival trainer
27. Deep learning-based ROI detection of AEH and EC on histopathology WSIs for predicting hormonal treatment response
28. Highly Enantiomerically Enriched Secondary Alcohols via Epoxide Hydrogenolysis
29. Corporate America Ruined Primary Care Too
30. Building a Community of Assessment: Final Report of the Research Library Impact Framework Pilot Initiative
31. Natural climate solutions and fire mitigation: early findings on the path to net zero: A mixed methods study on natural climate solutions, fire mitigation, and permanence
32. Introduction to Anti-Racist Theories
33. Voices from the Field of School Counseling: Promoting Anti-Racism in School Settings
34. Education 3.0
35. Education 3.0
36. Edith Stein’s Concept of Soul Revisited
37. Subcellular Fractionation Suitable for Studies of RNA and Protein Trafficking
38. Found Cumbering the Soil
39. Hemlock Hospice
40. Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)
41. Subcutaneous pythiosis in human treated successfully with antimicrobial treatment, debridement and immunotherapy
42. Shared Anchoring of Marine Renewable Energy Devices Utilizing Monopiles
43. Eat Breathe Thrive: an interpretative phenomenological analysis of a yoga-based eating disorder intervention
44. Distinct sets of molecular characteristics define tumor-rejecting neoantigens
45. End-to-end deep learning method for predicting hormonal treatment response in women with atypical endometrial hyperplasia or endometrial cancer
46. Supplementary Figure S9 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
47. Supplementary Figure S14 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
48. Supplementary Table S8 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
49. Supplementary Figure S11 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
50. Supplementary Figure S11 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.